Washington, Apr 23: A drug, currently under development, has been found effective in providing protection against damaging effects of radiation exposure.
The research team from University of Pittsburgh School of Medicine has found that experimental drug JP4-039 protects cells from being damaged by radiation exposure.
Lead researcher Dr Joel Greenberger, professor and chairman of the Department of Radiation Oncology at Pitt revealed that JP4-039 assists the mitochondria, the energy generator of all cells, in combating irradiation-induced cell death.